Additionally, activation of GIP receptors further enhances insulin secretion
Some Aetna insurance plans may cover GLP-1 medications like Wegovy or Zepbound for obesity
doi: 10.1001/jama.2024.3073 Summary Keywords obesity, obesity pharmacotherapy, precision medicine, personalized treatment, combination therapy, weight management, weight loss Citation Steenackers N, Toumassian J, Deleus E, Mertens A, Lannoo M, Pazmino S, van Laar ADE, Van der Schueren B and Vangoitsenhoven R (2025) Pharmacotherapy for obesity: are we ready to select, tailor and combine pharmacotherapy to achieve more ambitious goals
your provider will advise which approach works best for your specific trip duration and destination
Less commonly, GLP-1 receptor agonists including semaglutide have been associated with gallbladder disorders such as cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation)
If you have ever had pancreatitis